Cargando…
Susceptibility of caprine mastitis pathogens to tildipirosin, gamithromycin, oxytetracycline, and danofloxacin: effect of serum on the in vitro potency of current macrolides
Mastitis is a significant disease in dairy ruminants, causing economic losses to the livestock industry and severe risks to public health. Antibiotic therapy is one of the most crucial practices to treat mastitis, although the susceptibility of caprine mastitis pathogens to current antibiotics has n...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468077/ https://www.ncbi.nlm.nih.gov/pubmed/36097302 http://dx.doi.org/10.1007/s11274-022-03407-0 |
_version_ | 1784788333293993984 |
---|---|
author | Galecio, Juan Sebastian Escudero, Elisa Corrales, Juan Carlos García-Romero, Edgar de la Fe, Christian Hernandis, Verónica Marin, Pedro |
author_facet | Galecio, Juan Sebastian Escudero, Elisa Corrales, Juan Carlos García-Romero, Edgar de la Fe, Christian Hernandis, Verónica Marin, Pedro |
author_sort | Galecio, Juan Sebastian |
collection | PubMed |
description | Mastitis is a significant disease in dairy ruminants, causing economic losses to the livestock industry and severe risks to public health. Antibiotic therapy is one of the most crucial practices to treat mastitis, although the susceptibility of caprine mastitis pathogens to current antibiotics has not been tested under standard or modified incubation conditions. This work evaluated the in vitro activity of tildipirosin, gamithromycin, oxytetracycline, and danofloxacin against caprine mastitis pathogens incubated following standard conditions of Clinical and Laboratory Standards Institute (CLSI) and deviation method by 25% supplementation with goat serum. Mycoplasma agalactiae, Escherichia coli, Staphylococcus aureus, Streptococcus spp., and coagulase-negative Staphylococci (CNS) were isolated from dairy goats with mastitis in Spain. Minimum inhibitory concentrations (MICs) were determined using the broth microdilution technique. The lowest MIC(90) under standard conditions was obtained with danofloxacin for mastitis-causing pathogens. An exception was M. agalactiae, where danofloxacin and oxytetracycline obtained low values. However, after adding serum, gamithromycin showed the lowest MIC(50) for S. aureus, Streptococcus spp., and CNS. The lowest MIC(50) was obtained with all the antibiotics tested (< 0.125 µg/ml) against M. agalactiae. Supplementing with serum resulted in a significant variation in tildipirosin and gamithromycin MIC values for CNS, S. aureus, M. agalagtiae, and E. coli. In brief, the MIC for antibiotics used against mastitis should be determined under conditions closely resembling intramammary infections to obtain representative susceptibility patterns against mastitis pathogens. Caprine mastitis pathogens were broadly susceptible to danofloxacin under standard conditions. The potency of macrolides against caprine mastitis pathogens increases when serum is present in culture media. |
format | Online Article Text |
id | pubmed-9468077 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-94680772022-09-14 Susceptibility of caprine mastitis pathogens to tildipirosin, gamithromycin, oxytetracycline, and danofloxacin: effect of serum on the in vitro potency of current macrolides Galecio, Juan Sebastian Escudero, Elisa Corrales, Juan Carlos García-Romero, Edgar de la Fe, Christian Hernandis, Verónica Marin, Pedro World J Microbiol Biotechnol Research Mastitis is a significant disease in dairy ruminants, causing economic losses to the livestock industry and severe risks to public health. Antibiotic therapy is one of the most crucial practices to treat mastitis, although the susceptibility of caprine mastitis pathogens to current antibiotics has not been tested under standard or modified incubation conditions. This work evaluated the in vitro activity of tildipirosin, gamithromycin, oxytetracycline, and danofloxacin against caprine mastitis pathogens incubated following standard conditions of Clinical and Laboratory Standards Institute (CLSI) and deviation method by 25% supplementation with goat serum. Mycoplasma agalactiae, Escherichia coli, Staphylococcus aureus, Streptococcus spp., and coagulase-negative Staphylococci (CNS) were isolated from dairy goats with mastitis in Spain. Minimum inhibitory concentrations (MICs) were determined using the broth microdilution technique. The lowest MIC(90) under standard conditions was obtained with danofloxacin for mastitis-causing pathogens. An exception was M. agalactiae, where danofloxacin and oxytetracycline obtained low values. However, after adding serum, gamithromycin showed the lowest MIC(50) for S. aureus, Streptococcus spp., and CNS. The lowest MIC(50) was obtained with all the antibiotics tested (< 0.125 µg/ml) against M. agalactiae. Supplementing with serum resulted in a significant variation in tildipirosin and gamithromycin MIC values for CNS, S. aureus, M. agalagtiae, and E. coli. In brief, the MIC for antibiotics used against mastitis should be determined under conditions closely resembling intramammary infections to obtain representative susceptibility patterns against mastitis pathogens. Caprine mastitis pathogens were broadly susceptible to danofloxacin under standard conditions. The potency of macrolides against caprine mastitis pathogens increases when serum is present in culture media. Springer Netherlands 2022-09-13 2022 /pmc/articles/PMC9468077/ /pubmed/36097302 http://dx.doi.org/10.1007/s11274-022-03407-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Galecio, Juan Sebastian Escudero, Elisa Corrales, Juan Carlos García-Romero, Edgar de la Fe, Christian Hernandis, Verónica Marin, Pedro Susceptibility of caprine mastitis pathogens to tildipirosin, gamithromycin, oxytetracycline, and danofloxacin: effect of serum on the in vitro potency of current macrolides |
title | Susceptibility of caprine mastitis pathogens to tildipirosin, gamithromycin, oxytetracycline, and danofloxacin: effect of serum on the in vitro potency of current macrolides |
title_full | Susceptibility of caprine mastitis pathogens to tildipirosin, gamithromycin, oxytetracycline, and danofloxacin: effect of serum on the in vitro potency of current macrolides |
title_fullStr | Susceptibility of caprine mastitis pathogens to tildipirosin, gamithromycin, oxytetracycline, and danofloxacin: effect of serum on the in vitro potency of current macrolides |
title_full_unstemmed | Susceptibility of caprine mastitis pathogens to tildipirosin, gamithromycin, oxytetracycline, and danofloxacin: effect of serum on the in vitro potency of current macrolides |
title_short | Susceptibility of caprine mastitis pathogens to tildipirosin, gamithromycin, oxytetracycline, and danofloxacin: effect of serum on the in vitro potency of current macrolides |
title_sort | susceptibility of caprine mastitis pathogens to tildipirosin, gamithromycin, oxytetracycline, and danofloxacin: effect of serum on the in vitro potency of current macrolides |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468077/ https://www.ncbi.nlm.nih.gov/pubmed/36097302 http://dx.doi.org/10.1007/s11274-022-03407-0 |
work_keys_str_mv | AT galeciojuansebastian susceptibilityofcaprinemastitispathogenstotildipirosingamithromycinoxytetracyclineanddanofloxacineffectofserumontheinvitropotencyofcurrentmacrolides AT escuderoelisa susceptibilityofcaprinemastitispathogenstotildipirosingamithromycinoxytetracyclineanddanofloxacineffectofserumontheinvitropotencyofcurrentmacrolides AT corralesjuancarlos susceptibilityofcaprinemastitispathogenstotildipirosingamithromycinoxytetracyclineanddanofloxacineffectofserumontheinvitropotencyofcurrentmacrolides AT garciaromeroedgar susceptibilityofcaprinemastitispathogenstotildipirosingamithromycinoxytetracyclineanddanofloxacineffectofserumontheinvitropotencyofcurrentmacrolides AT delafechristian susceptibilityofcaprinemastitispathogenstotildipirosingamithromycinoxytetracyclineanddanofloxacineffectofserumontheinvitropotencyofcurrentmacrolides AT hernandisveronica susceptibilityofcaprinemastitispathogenstotildipirosingamithromycinoxytetracyclineanddanofloxacineffectofserumontheinvitropotencyofcurrentmacrolides AT marinpedro susceptibilityofcaprinemastitispathogenstotildipirosingamithromycinoxytetracyclineanddanofloxacineffectofserumontheinvitropotencyofcurrentmacrolides |